Biological: Clinical Trials

7 trials of Biological, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 2 unknown, 1 active not recruiting, 1 completed. 7 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Terminated 2, Unknown 2, Active not recruiting 1, Completed 1, Withdrawn 1
Phase 12Terminated 1, Unknown 1

Follow Biological: new trials by email Literature Review of Biological trials Research Report on Biological

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
AAV2-GDNF gene therapy, control surgery - Parkinson Disease
Phase 2Active not recruitingAskBio Inc592024-06-112026-11-05
Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial
Peripheral Intravenous (IV) infusion of LMSCs - Metabolic Disease, Endothelial Dysfunction
Phase 2WithdrawnLongeveron Inc.2023-12-012023-02-16
Clinical Trial of GAIA-102 for Advanced and Relapse NSCLC
Biological - Cell Therapy, NSCLC
Phase 1 / Phase 2TerminatedGAIA BioMedicine Inc.222021-12-012026-09-03
Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease
Biological - Severe COVID-19 Disease
Phase 2CompletedHospital Central Militar1502020-06-232021-05-10
Dendritic Cells for Type 1 Diabetes Mellitus (T1DM) Therapy
Biological - Treatment of Type I Diabetes Mellitus.
Phase 1 / Phase 2UnknownDiaVacs, Inc.902013-10-012013-10-23
Collagenase in the Treatment of Cellulite
Collagenase, Biological - Cellulite
Phase 2UnknownStony Brook University202013-02-012012-12-12
A Long Term Study of the Safety of Tanezumab When Administered By Subcutaneous Injections
Tanezumab 2.5 mg, Tanezumab 5 mg, Tanezumab 10 mg - Osteoarthritis, Knee, Osteoarthritis, Hip
Phase 2TerminatedPfizer6792009-11-172021-05-13

Conditions studied

Cellulite (1)  ·  Metabolic Diseases (1)  ·  Osteoarthritis, Hip (1)  ·  Osteoarthritis, Knee (1)  ·  Parkinson Disease (1)  ·  Severe Acute Respiratory Syndrome (1)

Sponsors

AskBio Inc (1)  ·  DiaVacs, Inc. (1)  ·  GAIA BioMedicine Inc. (1)  ·  Hospital Central Militar (1)  ·  Longeveron Inc. (1)  ·  Pfizer (1)  ·  Stony Brook University (1)

Countries

United States (4)  ·  Germany (1)  ·  Japan (1)  ·  Mexico (1)  ·  Poland (1)  ·  United Kingdom (1)

Top investigators

Alexander B Dagum, MD (1)  ·  Anthony Oliva, PhD (1)  ·  Carmen G Torres, MD (1)  ·  Marie A Badalamente, PhD (1)  ·  Yoshikazu Yonemitsu, MD, PhD (1)